Johns Hopkins Medicine
Health Newsfeed – Johns Hopkins Medicine PodcastsEpisodes
Episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
Mark All
Search Episodes...
Cancer of the esophagus can be challenging to treat, and when it’s diagnosed a number of studies are appropriate to fully evaluate the disease. That’s according to Richard Battafarano, director of thoracic surgery at Johns Hopkins. Battafarano:
Esophagus cancer awareness month has just ended, and Richard Battafarano, director of thoracic surgery at Johns Hopkins, says while some people may have this type of cancer and not know it, the majority will have a range of symptoms. Battafaran
Bladder cancer treatment is about to change dramatically based on a trial showing that adding an antibody to a toxic substance is much more effective than current treatments. Johns Hopkins Kimmel Cancer director William Nelson describes this cl
Stool based tests to screen for colorectal cancer have been around for some time and work pretty well. Now one of the most utilized ones has been improved, a clinical trial shows. William Nelson, director of the Kimmel Cancer Center … A stool
A blood test to screen for cancer is something of a Holy Grail, and now a new study describes one for colorectal cancer. Kimmel Cancer Center director William Nelson at Johns Hopkins says while there is still quite a bit … Is a better way to s
Pulse oximeters, vital for measuring how much oxygen is in someone’s blood, don’t work well in people with darker skin, multiple studies have shown. Ashraf Fawzy, a critical care medicine expert at Johns Hopkins, says even the degree to which …
Just how inaccurate are the devices used to measure oxygen in the blood, called pulse oximeters, in people with darker skin? That’s the question that Ashraf Fawzy, a critical care medicine expert at Johns Hopkins, and colleagues addressed in a
Just how inaccurate are the devices used to measure oxygen in the blood, called pulse oximeters, in people with darker skin? That’s the question that Ashraf Fawzy, a critical care medicine expert at Johns Hopkins, and colleagues addressed in a
Pulse oximeters are essential to measure someone’s level of oxygen in their blood, yet they haven’t been updated since the 1970s and they’re not well regulated by the FDA. That’s according to Ashraf Fawzy, a critical care medicine expert at …
If you’re a person with darker skin, a device to measure oxygen in your blood called a pulse oximeter may be inaccurate, sometimes extremely so, accumulating research shows. Ashraf Fawzy, a critical care medicine expert at Johns Hopkins and one
Pulse oximeters are devices used to measure how much oxygen is in someone’s blood, and they are critical in settings like ICUs. Yet research shows that in people of darker skin tones they can be wildly inaccurate. Ashraf Fawry, a … It’s high t
If you’re a woman going through menopause you may have chosen to go online for help. If so you may be the victim of a ‘femtech’ company. Wen Shen, a menopause expert at Johns Hopkins, explains. Shen: Basically they're there … What is a ‘femtec
Women may be experiencing overmedicalization as they transition through menopause, a recent Lancet series seems to suggest. Wen Shen, a menopause expert at Johns Hopkins, says that’s not her experience, since she sees many women who avoid phys
A recent Lancet series on menopause may result in many more women turning to the internet for help. That’s according to Wen Shen, a menopause expert at Johns Hopkins, who fears the series may have set back progress on bringing … Women in menop
As women transition through menopause, they should be offered conservative approaches that don’t rely on medicines. That’s one interpretation of a recent Lancet series on menopause, and Wen Shen, a menopause expert at Johns Hopkins, says while
Is menopause overmedicalized? That seems to be one conclusion of a recent series published in the Lancet on this life stage for women. Wen Shen, a menopause expert at Johns Hopkins, begs to disagree. Shen: It's unfortunate that they came … A n
Is menopause overmedicalized? That seems to be one conclusion of a recent series published in the Lancet on this life stage for women. Wen Shen, a menopause expert at Johns Hopkins, begs to disagree. Shen: It's unfortunate that they came … A n
An injectable drug called omalizumab now may be used to manage severe food allergies, the FDA has decided. Robert Wood, an allergy expert at Johns Hopkins, says the drug will only work if people are taking it. Wood: This is … Is lifelong treat
Omalizumab is an injectable drug just approved by the FDA to treat severe food allergies. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says risks discerned in the … Are there d
Consequences of food allergies can be life-threatening, which is why FDA approval of omalizumab to treat them is welcome. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says … Ar
Feeding very young children peanut products can assure that they don’t develop an allergy to peanut. Can this strategy be expanded to allergies to foods like milk, meat, or egg? Johns Hopkins allergy expert Robert Wood comments. Wood: There’s
Can food allergies be outgrown? Elizabeth Tracey reports Most people know about peanut allergy, since it impacts a lot of people, especially children. Can these allergies be outgrown? Robert Wood, an allergy expert at Johns Hopkins, says for mo
If you have a severe allergy to one food, you probably have the same issues with other foods, as well as allergies to things like pollen that you inhale. That’s according to Robert Wood, principal investigator on a study that … Severe food all
Food allergies are very often multiple and begin in childhood. Does this mean the newly approved omalizumab, given by injection, must be taken for the rest of someone’s life? Robert Wood, principal investigator on the study used by the FDA … A
The FDA has just approved a drug called omalizumab used to treat asthma to treat multiple, severe food allergy. Robert Wood, an allergy expert at Johns Hopkins and principal investigator on the study that demonstrated the drug’s efficacy, says
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us